Member Info for maestro1

Heleb

It depends how the mkt reacts, the old tech xenon 133 which is radioactive is 40 years old, the image is 2d and not clear.

Whereas our tech xenon 129 is 3d image, radiation free and the only tech which can visualise all 3 aspects of lung functions. Its far superior, in US there is 50m people who suffer from chronic lung disease, there are 13000 mri's in US, test will cost around $250.

The mkt is huge.. if they get fda approval tomorrow wont be surprised if we close to $1bn mkt cap in coming weeks. The mkt is huge...

House broker gave it 90% chance of fda approval.

Tech is the best and safe.

25 machines are already been sold for research purpose, over a 1000 peer review journals have been written about this tech.

Visualise all 3 aspects of lung functioning and is 3d image, no current lung imaging tech can do this. Xenon 129 is radiation free also.

90% of fda approval..

Trunky, its not 50/50, the broker has given a 90% chance of approval, this is rare.

Also watch this presentation between our ceo and amati and pay attention particular from 7mins in.

https://youtu.be/rWAZw3UKIJE

The ceo states alongs the line if your tech matches an already approved tech then it essentially approved. Our tech is superior to the 40 year old product which they did an h2h with in phase III trials.

Good luck

Only good to come out of this for the last 2 years is that gdr is debt free now.

Im finding it hard to value company at 20m.

Im really surprised Budd is still in charge, the writing was on the wall when they couldnt sell any pcr kits in the midst of pandemic.

Its all aihl now, what can the mkt value this at? They will need to do some phase III trials and then appy for nda with fda, which will take years.

Does the company warrant 20m mkt cap?

I should also include they plan to sell tech for $250 per scan, this is why they targeting usa first.

Big bucks..

Dulyred

500m mkt cap next week if they get fda approval.

I see if way above 1bn in 12 months.

Just looking at the numbers in usa, theres 13000 mri's in US alone. The broker forecast 480k scans per annum for only 240 mri's, which give revenues close to $170m.

Ceo states all hospitals will have polarisers in 10 years, the numbers become insane.

Fda hurdle then we on our way...

Dulyred

I think i got carried away. :)

£500m mkt cap better..

Cant wait for 5th.

Phase 3 success and fda approval are two totally different scenarios.

Its totally derisked with fda approval can easily see it valued over 500bn if thats the case

Expecting some action 2morrow, a bit of press over the weekend will be nice.

Trickyrich

What was your prev alias? One prev post only???

Traders...

Well my chips are in, 90% chance of approval..

Heleb

Pdufa date is 5th oct, its likely a decision will be made then.

25 polarisers are currently around the world for research purpose and are working well.

No i dont.

With the sp goin up in the right direction its looking good.

There is seller in background, all buys being soaked.

Once shifted this is flying.

Nice..

I guarantee this will go alot higher than current sp before the 5th oct..

Its due alot more.

The tech is great.